Newsfile Corp
17 Sept 2026, 11:52 UTC · 1h ago
Verdict
Headline takes no side. We score RHEL +0.60 across four claims — strongly bullish.
+0.60strongly bullish
More positive than 75% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish · 2 new · 2 priced in
Filament Health entered into a supply and licensing agreement with the Centre for Human Drug Research (CHDR) for PEX010 in a low and medium dose psilocybin study.
Newpress release dated September 17, 2026
More positive than 65% of claims this week
Filament Health currently supports more than 80 academic and philanthropic research studies worldwide with PEX010.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 54% of claims this week
The company intends to introduce a 0.5 mg dose of PEX010 to complement its existing 1, 5, and 25 mg offerings.
Newpress release dated September 17, 2026
More positive than 45% of claims this week
Rhelion completed the acquisition of Filament Health and its 77 issued patents on April 30, 2026.
Priced inevent occurred April 30, 2026
So whatThe integration of these 13 patent families provides the long-term IP moat required to defend margins against generic botanical psilocybin.
More positive than 45% of claims this week
Which stocks this story touches
More positive than 75% of ticker scores this week
The company's subsidiary has entered into a new supply and licensing agreement for its psilocybin drug candidate PEX010.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
19h ago
—
No price for RHEL right now — the quote feed didn't answer.
RHEL chart →
